Structure and design of potent and selective cathepsin K inhibitors

被引:100
作者
Yamashita, DS
Smith, WW
Zhao, BG
Janson, CA
Tomaszek, TA
Bossard, MJ
Levy, MA
Oh, HJ
Carr, TJ
Thompson, SK
Ijames, CF
Carr, SA
McQueney, M
DAlessio, KJ
Amegadzie, BY
Hanning, CR
AbdelMeguid, S
DesJarlais, RL
Gleason, JG
Veber, DF
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT MED CHEM,KING OF PRUSSIA,PA 19406
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT MACROMOL SCI,KING OF PRUSSIA,PA 19406
[3] SMITHKLINE BEECHAM PHARMACEUT,DEPT MOL RECOGNIT,KING OF PRUSSIA,PA 19406
[4] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHYS & STRUCT CHEM,KING OF PRUSSIA,PA 19406
[5] SMITHKLINE BEECHAM PHARMACEUT,DEPT PROT BIOCHEM,KING OF PRUSSIA,PA 19406
[6] SMITHKLINE BEECHAM PHARMACEUT,DEPT GENE EXPRESS SCI,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1021/ja972204u
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
[No abstract available]
引用
收藏
页码:11351 / 11352
页数:2
相关论文
共 16 条
[1]  
AMOS HE, 1985, IMMUNOTOXICOLOGY IMM, P207
[2]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[3]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[4]   Crystal structure of human cathepsin K complexed with a potent inhibitor [J].
McGrath, ME ;
Klaus, JL ;
Barnes, MG ;
Bromme, D .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (02) :105-109
[5]   ACTIVATED KETONES AS POTENT REVERSIBLE INHIBITORS OF INTERLEUKIN-1-BETA CONVERTING-ENZYME [J].
MJALLI, AMM ;
CHAPMAN, KT ;
MACCOSS, M ;
THORNBERRY, NA ;
PETERSON, EP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (16) :1965-1968
[6]   VINYL SULFONES AS MECHANISM-BASED CYSTEINE PROTEASE INHIBITORS [J].
PALMER, JT ;
RASNICK, D ;
KLAUS, JL ;
BROMME, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3193-3196
[7]  
RANDO RR, 1984, PHARMACOL REV, V36, P111
[8]   ON SIZE OF ACTIVE SITE IN PROTEASES .I. PAPAIN [J].
SCHECHTER, I ;
BERGER, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 27 (02) :157-+
[9]   X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A PAPAIN LEUPEPTIN COMPLEX [J].
SCHRODER, E ;
PHILLIPS, C ;
GARMAN, E ;
HARLOS, K ;
CRAWFORD, C .
FEBS LETTERS, 1993, 315 (01) :38-42
[10]  
Segel I. H., 1975, ENZYME KINETICS, p[107, 132]